Literature DB >> 11083802

Correlation of susceptibility of immature mice to fungal infection (blastomycosis) and effector cell function.

A Ganer1, E Brummer, D A Stevens.   

Abstract

Immature mice are highly susceptible to blastomycosis, which is similar to other mycoses and has parallels in humans. The murine susceptibility is noteworthy in that it persists beyond the development of resistance to other, nonfungal pathogens and the maturation of most immune functions. As the susceptibility to blastomycosis appeared to be related to an early event after infection, primary effector cell function was studied. We found that peritoneal inflammatory cells, enriched for neutrophils, from immature (3-week-old) mice killed nonphagocytizable Blastomyces dermatitidis cells less (25%) than did cells from mature (8-week) mice (70%) (P<0.01), a defect intrinsic to the neutrophils. This correlated with an impaired immature cell oxidative burst. Killing of phagocytizable Candida albicans was not significantly different, 73 versus 87%. Thioglycolate-elicited cells were more impaired; killing of B. dermatitidis was insignificant, and killing of C. albicans was more impaired in immature (16% killing) than in mature (45%) cells (P<0.02). Peripheral blood neutrophils from mature animals killed B. dermatitidis (41%) more than did those from immature animals (10%) (P<0.02); C. albicans was killed efficiently by both. Resting or activated peritoneal macrophages from both types of animals showed no differences in B. dermatitidis killing. These results suggest that the susceptibility of immature mice is related at least in part to the depressed capacity of their neutrophils to kill B. dermatitidis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083802      PMCID: PMC97787          DOI: 10.1128/IAI.68.12.6833-6839.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  75 in total

Review 1.  Antimicrobial defenses in the neonate.

Authors:  P G Quie
Journal:  Semin Perinatol       Date:  1990-08       Impact factor: 3.300

2.  Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages.

Authors:  R C Allen; L D Loose
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

3.  The enhancement of the virulence of Candida albicans in mice.

Authors:  S B SALVIN; J C CORY; M K BERG
Journal:  J Infect Dis       Date:  1952 Mar-Apr       Impact factor: 5.226

4.  Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response.

Authors:  H C Morse; B Prescott; S S Cross; P W Stashak; P J Baker
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

5.  Comparative mitogenic responses of T-cells and B-cells in spleens of mice of varying age.

Authors:  S G Rabinowitz
Journal:  Immunol Commun       Date:  1975

6.  Age related changes in the in vitro immune response: increased suppressor activity in immature and aged mice.

Authors:  R H DeKruyff; Y T Kim; G W Siskind; M E Weksler
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates.

Authors:  A O Shigeoka; J I Santos; H R Hill
Journal:  J Pediatr       Date:  1979-09       Impact factor: 4.406

8.  Activation of murine polymorphonuclear neutrophils for fungicidal activity with supernatants from antigen-stimulated immune spleen cell cultures.

Authors:  E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Changes in suppressor mechanisms during postnatal development in mice.

Authors:  C E Calkins; O Stutman
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

10.  Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes.

Authors:  D E Mosier; B M Johnson
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.